Malignant eccrine hidradenoma.
Cauthon DJ, Worthen T, Freed L, DeComas AM.
J Am Podiatr Med Assoc. 2013 Jul-Aug;103(4):333-6. doi: 10.7547/1030333.
[Hidradenoma papilliferum].
Elouarradi R, Hocar O.
Pan Afr Med J. 2014 Apr 14;17:274. doi: 10.11604/pamj.2014.17.274.4177. eCollection 2014.
Hidradenocarcinoma.
de Lima AA, Santos M, de Morais PM, Rodrigues CAC.
An Bras Dermatol. 2021 Mar-Apr;96(2):251-253. doi: 10.1016/j.abd.2020.03.023. Epub 2021 Feb 5.
Hidradenoma papilliferum.
MEEKER JH, NEUBECKER RD, HELWIG EB.
Am J Clin Pathol. 1962 Feb;37:182-95. doi: 10.1093/ajcp/37.2.182.
Lymph Node Involvement by a Clear Cell Nodular Hidradenoma-Like Tumor of Uncertain Malignant Potential.
Au B, Sidiropoulos KG, Ghazarian D, Sidiropoulos M.
Am J Dermatopathol. 2017 Dec;39(12):953-954. doi: 10.1097/DAD.0000000000000808.
Malignant clear cell hidradenoma.
Touma D, Laporte M, Goossens A, Ledoux M.
Dermatology. 1993;186(4):284-6. doi: 10.1159/000247377.
[Nodular hidradenoma].
Soua Y, Mohamed M, Belhajali H, Njim L, Youssef M, Zakhama A, Zili J.
Ann Dermatol Venereol. 2013 Feb;140(2):152-3. doi: 10.1016/j.annder.2012.11.002. Epub 2012 Dec 28.
[Malignant nodular hidradenoma. A clinical case].
De Toma G, Plocco M, Nicolanti V, Cavallaro G, Amato D, Letizia C.
Minerva Chir. 2000 Mar;55(3):185-7.
[Poroid hidradenoma].
Monteagudo B, Iglesias B, de la Torre C, Paredes C, Vázquez-Blanco M, Ginarte M, Labandeira J.
Actas Dermosifiliogr. 2005 Jul-Aug;96(6):398-9. doi: 10.1016/s0001-7310(05)73100-8.
Poroid hidradenoma: a benign lesion masking as a malignant breast tumor.
Liaqat H, Ammad Ud Din M, Malik D.
QJM. 2020 Oct 1;113(10):749-750. doi: 10.1093/qjmed/hcaa109.
